The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirsch, R.
Right arrow Articles by Bluestone, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirsch, R.
Right arrow Articles by Bluestone, J. A.

The Journal of Immunology, Vol 140, Issue 11 3766-3772, Copyright © 1988 by American Association of Immunologists

ARTICLES

Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses

R Hirsch, M Eckhaus, H Auchincloss Jr, DH Sachs and JA Bluestone
Transplantation Biology Section, National Cancer Institute, Bethesda, MD 20892.

Anti-T3 mAb are being increasingly used clinically in the treatment of organ graft rejection. However, there has not previously been a murine model in which the effects of these mAb on the immune system could be studied in vivo. We have established such a model using the anti-murine- T3 mAb, 145-2C11. Administration of 145-2C11 led to rapid depletion of T cells from peripheral blood and suppression of skin graft rejection. However, depletion of T cells from spleen and lymph node was both delayed and incomplete. Full recovery of T cell number was dependent on the presence of a thymus, but treatment of thymectomized animals revealed that depletion was not the mechanism by which the mAb induced immunosuppression. Rather, alterations in TCR expression may play a more important role. TCR had modulated from T cells in spleen and lymph node early after treatment, and TCR expression remained subnormal for at least 51 days posttreatment. However, subnormal TCR expression alone could not fully explain the observed T cell dysfunction, inasmuch as a period of time existed after TCR re-expression during which T cells appeared to be anergic to CTL and MLR reactivity. These findings implicate T cell dysfunction as an important element in the induction of immunosuppression after anti-T3 administration.


This article has been cited by other articles:


Home page
 CirculationHome page
S. Steffens, F. Burger, G. Pelli, Y. Dean, G. Elson, M. Kosco-Vilbois, L. Chatenoud, and F. Mach
Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice
Circulation, October 31, 2006; 114(18): 1977 - 1984.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
N. Miura, M. Yamamoto, M. Fukutake, N. Ohtake, S. Iizuka, A. Ishige, H. Sasaki, K. Fukuda, T. Yamamoto, and S. Hayakawa
Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments
Int. Immunol., May 1, 2005; 17(5): 513 - 522.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. P. Kohm, J. S. Williams, A. L. Bickford, J. S. McMahon, L. Chatenoud, J.-F. Bach, J. A. Bluestone, and S. D. Miller
Treatment with Nonmitogenic Anti-CD3 Monoclonal Antibody Induces CD4+ T Cell Unresponsiveness and Functional Reversal of Established Experimental Autoimmune Encephalomyelitis
J. Immunol., April 15, 2005; 174(8): 4525 - 4534.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Andris, S. Denanglaire, F. de Mattia, J. Urbain, and O. Leo
Naive T Cells Are Resistant to Anergy Induction by Anti-CD3 Antibodies
J. Immunol., September 1, 2004; 173(5): 3201 - 3208.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. J. James, L. Belaramani, K. Prodromidou, A. Datta, S. Nourshargh, G. Lombardi, J. Dyson, D. Scott, E. Simpson, L. Cardozo, et al.
Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism
Blood, September 15, 2003; 102(6): 2173 - 2179.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Tang, J. A. Smith, G. L. Szot, P. Zhou, M.-L. Alegre, K. J. Henriksen, C. B. Thompson, and J. A. Bluestone
CD28/B7 Regulation of Anti-CD3-Mediated Immunosuppression In Vivo
J. Immunol., February 1, 2003; 170(3): 1510 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M Merger, J L Viney, R Borojevic, D Steele-Norwood, P Zhou, D A Clark, R Riddell, R Maric, E R Podack, and K Croitoru
Defining the roles of perforin, Fas/FasL, and tumour necrosis factor {alpha} in T cell induced mucosal damage in the mouse intestine
Gut, August 1, 2002; 51(2): 155 - 163.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. G. von Herrath, B. Coon, T. Wolfe, and L. Chatenoud
Nonmitogenic CD3 Antibody Reverses Virally Induced (Rat Insulin Promoter-Lymphocytic Choriomeningitis Virus) Autoimmune Diabetes Without Impeding Viral Clearance
J. Immunol., January 15, 2002; 168(2): 933 - 941.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. T. Meijer, R. P. Koopmans, I. J. M. ten Berge, and P. T. A. Schellekens
Pharmacokinetics of Murine Anti-Human CD3 Antibodies in Man Are Determined by the Disappearance of Target Antigen
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 346 - 353.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. O'Herrin, J. E. Slansky, Q. Tang, M. A. Markiewicz, T. F. Gajewski, D. M. Pardoll, J. P. Schneck, and J. A. Bluestone
Antigen-Specific Blockade of T Cells In Vivo Using Dimeric MHC Peptide
J. Immunol., September 1, 2001; 167(5): 2555 - 2560.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Dao, M. Exley, W. Z. Mehal, S. M. A. Tahir, S. Snapper, M. Taniguchi, S. P. Balk, and I. N. Crispe
Involvement of CD1 in Peripheral Deletion of T Lymphocytes Is Independent of NK T Cells
J. Immunol., March 1, 2001; 166(5): 3090 - 3097.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. L. O'Brien, X. Yin, S. A. Huber, K. Ikuta, and W. K. Born
Depletion of a {gamma}{delta} T Cell Subset Can Increase Host Resistance to a Bacterial Infection
J. Immunol., December 1, 2000; 165(11): 6472 - 6479.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
B. Metzler, M. Mayr, H. Dietrich, M. Singh, E. Wiebe, Q. Xu, and G. Wick
Inhibition of Arteriosclerosis by T-Cell Depletion in Normocholesterolemic Rabbits Immunized With Heat Shock Protein 65
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1905 - 1911.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. M. Hall, L. Fava, J. Chen, K. M. Plain, R. A. Boyd, S. T. Spicer, and M. F. Berger
Anti-CD4 Monoclonal Antibody-Induced Tolerance to MHC-Incompatible Cardiac Allografts Maintained by CD4+ Suppressor T Cells That Are Not Dependent upon IL-4
J. Immunol., November 15, 1998; 161(10): 5147 - 5156.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
J. A. Smith, J. Y. Tso, M. R. Clark, M. S. Cole, and J. A. Bluestone
Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy
J. Exp. Med., April 21, 1997; 185(8): 1413 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
E. Schneider, V. Salaün, A. Ben Amor, and M. Dy
Hematopoietic Changes Induced by a Single Injection of Anti-CD3 Monoclonal Antibody into Normal Mice
Stem Cells, March 1, 1997; 15(2): 154 - 160.
[Abstract] [Full Text]

Home page
 ScienceHome page
J. Ellenhorn, R Hirsch, H Schreiber, and J. Bluestone
In vivo administration of anti-CD3 prevents malignant progressor tumor growth
Science, October 28, 1988; 242(4878): 569 - 571.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.